Rebirth of science and technology academic master

Chapter 337 Paper Published

The publication of the paper is only a preliminary result.

It represents the results of laboratory research, there are no problems in theoretical research, and there are sufficient experimental samples and experimental data.

But a little mouse will be a little mouse after all, and a person will be a person after all!

So the next step will be to enter the second phase, which is to cooperate with hospitals and scientific research institutions to carry out clinical trials. In China, the application of a drug must undergo phase three clinical trials in China to ensure safety before it is allowed to be officially approved as a drug. drug.

Many people are blaming China, saying why there are many drugs with very good efficacy overseas but they are not allowed to enter the Chinese market, causing patients to lose their lives without drugs. In fact, it is because these drugs are only undergoing clinical trials overseas, but they have not carried out phase III clinical trials in China in accordance with Chinese regulations. Since they have not followed Chinese regulations, the relevant departments will naturally not allow them to enter.

Who knows whether the overseas clinical trials of these drugs are fraudulent? Who knows if these drugs can be applied to Westerners, but whether they can be applied to Chinese people?

And it’s not just phase III clinical trials, there will even be phase IV clinical trials and even EAP clinical trials when necessary.

Qin Yuanqing did not pay much attention to the clinical trial stage and left it to researchers and partner hospitals.

"Journal of Shuimu Natural Science" was founded in 1986. Today, its composite impact factor is 1.612 and its comprehensive impact factor is 1.138. It only ranks second among university journals nationwide and ranks around one hundred nationally. As for its international rankings, The ranking above belongs to the third-rate level.

Although "Journal of Shuimu Natural Science" also has excellent papers that have been included in SCI, most of the content is not influential. Only 4 papers were selected last year.

The editorial department of "Journal of Shuimu Natural Science" just received nine papers, and they didn't take it seriously at first. After all, the purpose of "Journal of Shuimu Natural Science" is to provide teachers and students of our school with a good platform for publishing content. Precisely because of this, "Shui Mu Natural Science Journal" will not strive for ranking.

But when they saw that the corresponding author of the paper was Qin Yuanqing, the first author was Yan Ning, the second author was Guo Zhenhua, and other 20 researchers, and the same was true for nine papers, the staff immediately reported it to the editor-in-chief.

"What? You said Academician Qin submitted a manuscript to us?" Luo Gang was shocked when he heard this.

Although he is the editor-in-chief of "Journal of Shuimu Natural Science", his status is completely incomparable with Qin Yuanqing, and even lower than Yan Ning. Just like Yan Ning, he will not submit his paper to "Journal of Shuimu Natural Science" at all, and It is submitted to top international journals such as "Nature", "Science", and "Cell".

Then Luo Gang realized that the opportunity of "Journal of Shuimu Natural Science" had come. Luo Gang was ecstatic and called the executive deputy editor, deputy editor, and editorial board director.

"Lao Luo, are you right?" Deputy Executive Editor Zhong Weimin seemed to think he heard wrongly.

"Look, the papers are here. There are nine papers in total, all about myocarditis." Luo Gang said, "But I don't understand this, so I have to find experts to review the papers."

When others took a look, it turned out that the corresponding author of the paper was signed by Qin Yuanqing. Six of the nine papers were written by Yan Ning and three by Guo Zhenhua.

"Lao Luo, what are you still reviewing? Who doesn't know now that Academician Qin's laboratory is the only one in the country and one of the best in the world. Can you find a bigger expert to review the manuscript?" Zhong Weimin curled his lips and said: "Not yet. It's better to study "Shuimu Mathematics Chronicle" and "Physics and Engineering" and just publish the papers directly."

Others think so!

Look, everyone was about the same at first, but in just a few years, "Chronicles of Mathematics" and "Physics and Engineering" have left them behind and become China's first-class and international first-class journals, becoming must-orders for major universities and related companies around the world. Journals, although the two journals are still part of the Shuimu Publishing Center, they have their own independent offices, and the reviewers invited are all big names in the industry, and the papers accepted are from all over the world. It is not like they want to invite a It is not easy for first-class scholars.

The biggest contributor to this is Qin Yuanqing. "Shui Mu Mathematics Chronicle" and "Physics and Engineering" are completely unbeatable.

The emperor takes turns and comes to my house next year!

Finally now, it's their turn for "Journal of Shuimu Natural Science"!

When they think that "Acta Shuimu Natural Science" will advance by leaps and bounds in their hands and become a world-class journal, it will be worth their while to die.

Therefore, the nine papers were published in a special issue of Shuimu Natural Science Journal without changing the words of the papers.

As a result, "Shui Mu Natural Science Journal" became popular!

Throughout China, everyone knew that Qin Yuanqing neglected his job, established a laboratory, and switched to chemistry and physics. The laboratory level reached the top level in the world, and nearly 10 billion funds were invested.

The previous lithium-air battery shocked the whole world and triggered a major turmoil in the energy structure. The lithium battery, which was originally developed with great success, was frozen in the cold northwest wind before it reached its peak. The price of oil fell sharply just as it was about to rise. A wave.

So as soon as I heard that the laboratory published nine papers in Shuimu Natural Science Journal, these papers immediately became popular.

Even medical research institutions and hospitals immediately ordered "Shui Mu Natural Science Journal", so that the original 20,000 copies of "Shui Mu Natural Science Journal" were ordered out in less than one day. Science News had to reprint it.

A day later, major medical research institutions, especially laboratories studying myocarditis, were conducting experiments based on the paper.

The results were tested on the blood of sick mice, and the changes in the proportion, number, serum, etc. of various immune cells and related data were basically consistent with the paper.

Regarding the 'myocarditis-specific factors', they have also been discovered, which is the same as the paper.

All the researchers who conducted the verification were shocked and heartbroken. You must know that every year, the state allocates hundreds to tens of millions of yuan for scientific research on genes, just to understand the pathological mechanisms. So far, the research results are still very little.

If nothing else happens, research on pathological mechanism projects like this will continue in the next few years or more, and a lot of funding will continue to be invested.

But now, less than a year after its establishment, Qin Yuanqing's laboratory has solved the mechanism of viral myocarditis and developed a specific drug to solve this pathology.

I don’t know how many researchers cried bitterly because they really lived like a dog.

The popularity and influence of the paper are still expanding, from China to surrounding areas, and then to the entire world.

But before the paper was sold abroad, several major medical giants had already approached Qin Yuanqing through various connections.

"Academician Qin, this is President Zhou of Shanghai Pharmaceutical (Group) Co., Ltd.!" Principal Chen introduced a middle-aged man.

Shanghai Pharmaceutical (Group) Co., Ltd. is a state-controlled pharmaceutical industry group with an annual turnover of about 140 billion yuan. It is among the top 500 enterprises in China.

Qin Yuanqing frowned slightly. These companies were really born in the Year of the Dog. Less than three days after the paper was published, they were already looking for connections.

Then looking at other people, including Huaxia Pharmaceutical Corporation, Yangcheng Pharmaceutical Group Co., Ltd., TJ Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., etc., it can be said that all the top ten giants of Huaxia Pharmaceutical are here.

The CEOs of these pharmaceutical groups all looked polite and said compliments. There was really nothing they could do about it. Qin Yuanqing was different from other researchers. Other researchers may have high technical levels, but that's it. Their monthly salary may be only one yuan. Ten thousand. But Qin Yuanqing is different. Qin Yuanqing is a super rich man himself, and even they feel the pressure from his terrifying net worth.

His wealth exceeds 200 billion US dollars, which is higher than the market value of the top ten pharmaceutical companies. What's more important is that Qin Yuanqing's status is above them. He can directly reach Tianting's existence, but they are still incomparable. It's a notch or two down.

They didn't have any friendship with Qin Yuanqing, so they paid a lot of favors. After seven or eight attempts, they finally got Principal Chen to contact Qin Yuanqing.

"Boss bosses, why are you here to see me?" Qin Yuanqing didn't know them, so naturally he didn't give them a good look.

Originally, he was preparing to attend the World Congress of Chinese Mathematicians. This year, the Seventh World Congress of Chinese Mathematicians was held at Shuimu University. About two thousand mathematicians from all over the world gathered at Tsinghua University.

Although the conference will officially open tomorrow, Qin Yuanqing still needs to receive some guests in person. After all, he is now a banner for Chinese mathematicians, and he also needs to promote exchanges among Chinese mathematicians at home and abroad.

Qin Yuanqing previously donated 50 million to the World Congress of Chinese Mathematicians to encourage exchanges between mathematicians at home and abroad, as well as to cultivate and support the younger generation of mathematicians.

As a result, Principal Chen begged him to come to the principal's office, saying that if he didn't come, he would be shameless.

When the CEOs of the top ten pharmaceutical companies heard this, their hearts twitched and their eyelids twitched.

If other people had seen such an attitude, they would have taken action to teach the young man a lesson, but at this time no one dared to fart.

Sure enough, just as Qin Yuanqing thought, these people came here for the specific medicine for myocarditis and wanted to obtain patent authorization.

Qin Yuanqing sighed in his heart.

To be honest, these domestic pharmaceutical companies are very disappointing. China's huge pharmaceutical market allows overseas pharmaceutical giants to conquer the city and make huge profits every year.

And obviously there is a huge market, so you should have strong bargaining power. Just like going to the market to purchase large quantities of materials, it is always cheaper than buying small quantities individually. Even grandparents know this truth.

However, every year the negotiations fail, pitifully, and then the overseas pharmaceutical giants are allowed to make huge profits. The Chinese pharmaceutical market is like a girl wearing tulle, allowing the overseas pharmaceutical giants to play whatever they want.

Please subscribe~~Subscriptions have dropped a bit recently